MoneyWorks4Me

Kilitch Drugs (India) informs about closure of trading window

10 May 2017 Evaluate

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Kilitch Drugs (India) has informed that the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the year ended March 31, 2017 from May 10, 2017 to June 01, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..